• All
  • Primary Antibodies
  • Conjugated Antibodies for IF
  • Conjugated Antibodies for FC
  • Secondary Antibodies
  • Antibody Labeling KitsNew
  • ELISA Kits
  • IHC Kits
  • Magnetic Cell Separation Kits
  • Cytokines & Growth Factors
  • Neutralizing/activating Antibodies
  • Nanobody-based Reagents
  • Accessory Products and Kits
  • Fusion Proteins
×
×
Host
0
Species Reactivity
0
Species Reactivity
0
Conjugate
0
Conjugate
0
Compatible Species
0
Conjugate
0

Bendazac L-lysine

Bendazac L-lysine (Bendazaco lisina) 是一种能够控制白内障的药物。它可以保护患者的视力水平，延缓手术干预的需要。

CAS号

81919-14-4

分子式

C22H28N4O5

主要靶点

Others

仅限科研使用

Cat No : CM05464

Print datasheet

Synonyms

Bendazaco lisina|Bendazac lysine|苄达赖氨酸

验证数据展示

  • CAS No.: 81919-14-4

    Bendazac L-lysine
    CAS#: 81919-14-4

产品信息

Bendazac L-lysine (Bendazaco lisina) is an agent introduced for the management of cataracts, protecting the level of vision in patients, thus delaying the need for surgical intervention.

CAS号 81919-14-4
分子式 C22H28N4O5
主要靶点 Others
主要通路 其他
分子量 428.48
纯度 99.91%， 此纯度可做参考，具体纯度与批次有关系，可咨询客服
储存条件 Powder: -20°C for 3 years | In solvent: -80°C for 1 year
别名 Bendazaco lisina|Bendazac lysine|苄达赖氨酸

溶解度

DMSO:2.41 mg/mL (5.62 mM),Sonification is recommended.

参考文献

1.Iuliano G, et al. Enzyme. 1989;42(4):235-7.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
=
×
×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
×
=
×
C1   V1   C2   V2